A panel of exerts discussed key takeaways happening in the field of HER2+ metastatic breast cancer.
ONCOLOGY Vol 40, Issue 4
A panel of exerts discussed key takeaways happening in the field of HR+/HER2– breast cancer.
A panel of exerts discussed key takeaways happening in the field of cutaneous squamous cell carcinoma.
The 2025 ICE-T Symposium highlighted expansion beyond BCMA to additional targets such as GPRC5D and FcRH5.
Julie M. Vose, MD, MBA, discussed how the digital age is impacting oncology care.
Management strategies for oxybutynin-induced xerostomia include hydration, sugar-free gum, and humidification.
Advertisement
Advertisement
Trending on CancerNetwork
1
Real-World Teclistamab Shows Deep Responses in R/R Multiple Myeloma Cohort
2
ArteraAI Prostate Test Added to NCCN Guidelines for BCR After Prostatectomy
3
Adding Pembrolizumab to SBRT Does Not Improve EFS in Early-Stage NSCLC
4
Virtuoso Robotic System Earns FDA De Novo Nod for En Bloc Bladder Resection
5